In a previous retrospective study, we demonstrated that falls are common and often injurious in dominant spinocerebellar ataxias (SCAs) and that nonataxia features play an important role in these falls. Retrospective surveys are plagued by recall bias for the presence and details of prior falls. We therefore sought to corroborate and extend these retrospective findings by means of a prospective extension of this fall study. 113 patients with SCA1, SCA2, SCA3 or SCA6, recruited from the EuroSCA natural history study, were asked to keep a fall diary in between their annual visits to the participating centres. Additionally, patients completed a detailed questionnaire about the first three falls, to identify specific fall circumstances. Relevant disease characteristics were retrieved from the EuroSCA registry. 84.1% of patients reported at least one fall during a time period of 12 months. Fall-related injuries were common and their frequency increased with that of falls. The presence of nonataxia symptoms was associated with a higher fall frequency. This study confirms that falls are a frequent and serious complication of SCA, and that the presence of nonataxia symptoms is an important etiological factor in its occurrence.

1.
Durr A: Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 2010;9:885–894.
2.
Fonteyn EM, Schmitz-Hubsch T, Verstappen CC, et al: Falls in spinocerebellar ataxias: results of the EuroSCA Fall Study. Cerebellum 2010;9:232–239.
3.
Jacobi H, Bauer P, Giunti P, et al: The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology 2011;77:1035–1041.
4.
Schmitz-Hubsch T, du Montcel ST, Baliko L, et al: Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006;66:1717–1720.
5.
Schmitz-Hubsch T, Coudert M, Bauer P, et al: Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology 2008;71:982–989.
6.
Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH: Prospective assessment of falls in Parkinson’s disease. J Neurol 2001;248:950–958.
7.
van de Warrenburg BP, Steijns JA, Munneke M, Kremer BP, Bloem BR: Falls in degenerative cerebellar ataxias. Mov Disord 2005;20:497–500.
8.
van der Marck MA, Overeem S, Klok PC, Bloem BR, Munneke M: Evaluation of the falls telephone: an automated system for enduring assessment of falls. J Am Geriatr Soc 2011;59:340–344.
9.
Ilg W, Synofzik M, Brotz D, Burkard S, Giese MA, Schols L: Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology 2009;73:1823–1830.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.